CBS 2019
CBSMD教育中心
中 文

Scientific Library

Abstract

Recommended Article

2018 ACC Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease A Report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways Mechanisms and diagnostic evaluation of persistent or recurrent angina following percutaneous coronary revascularization Variation in Revascularization Practice and Outcomes in Asymptomatic Stable Ischemic Heart Disease Healed Culprit Plaques in Patients With Acute Coronary Syndromes Complete Versus Culprit-Only Lesion Intervention in Patients With Acute Coronary Syndromes Complete or Culprit-Only Revascularization for Patients With Multivessel Coronary Artery Disease Undergoing Percutaneous Coronary Intervention: A Pairwise and Network Meta-Analysis of Randomized Trials Relation of prior statin and anti-hypertensive use to severity of disease among patients hospitalized with COVID-19: Findings from the American Heart Association’s COVID-19 Cardiovascular Disease Registry Implications of Alternative Definitions of Peri-Procedural Myocardial Infarction After Coronary Revascularization

ConsensusNovember 2018

JOURNAL:J Am Coll Cardiol. Article Link

2018 ACC Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease A Report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways

Writing Committee, Sandeep RD, Brendan M et al. Keywords: ASCVD; cardiovascular risk reduction; diabetes; Expert Consensus; Decision Pathway; GLP-1RA; SGLT2 inhibitor; T2D

FULL TEXT PDF